StudyFinder

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

514 Study Matches

Brief Smartphone Treatment Study for Obsessive-Compulsive Disorder

This study is testing whether adding brief activities to a standard treatment for obsessive-compulsive disorder (OCD), called Exposure and Response Prevention (ERP), can make the treatment easier to use, help people stay engaged, and improve treatment outcomes when it is delivered entirely through a smartphone app without a therapist. ERP is a well-established treatment for OCD. It involves gradually facing situations that cause anxiety or discomfort while practicing not responding with compulsions or other behaviors used to reduce that discomfort. ERP can be very effective, but many people with OCD do not have access to this type of treatment. Smartphone-based versions may help make treatment more accessible, although some people find it difficult to stay engaged with treatment on their own. We will recruit up to 340 adults with OCD from across the United States through online advertising. After completing screening, including a diagnostic interview, participants will receive training on the study procedures and will be randomly assigned to one of two 14-day smartphone programs. Both groups will complete the same ERP exercises and receive six brief prompts on their phone each day. The two programs will differ in the types of brief activities included alongside the ERP exercises. These activities are designed to help us understand whether adding a particular type of activity to ERP improves participants’ experience with and engagement in treatment. Participants will complete questionnaires and brief interviews before and after the 14-day program, as well as additional assessments during the program and one month later. Participants can receive up to $100 in compensation for completing study check-ins. Compensation is based on completing the study assessments and daily check-ins and is not dependent on completing the ERP exercises.

The purpose of this study is to examine whether the effectiveness of a fully online exposure and response prevention (ERP) treatment program for OCD symptoms. The findings may help improve OCD treatments and make them more accessible and effective. Participation involves: - Complete a 10-minute questionnaire and initial phone screen to determine initial eligibility - Attend an approximately 45-minute online audio and videorecorded clinical interview to determine whether you are eligible for the study. - If eligible, attend an approximately 75-minute online baseline visit that includes an audio and videorecorded clinical interview, questionnaires, and training on the study treatment procedures. - Complete a 14-day smartphone-based treatment. You will receive 6 prompts each day through a smartphone application. Four prompts will take less than 5 minutes and will ask about your OCD symptoms and daily experiences. Two prompts will take approximately 30 minutes and will include an exposure exercise designed to help you practice facing anxiety or uncertainty related to OCD without performing compulsions. - Attend an approximately 60-minute online mid-treatment visit on Day 7, which will include audio and videorecorded clinical interview and questionnaires. - Attend an approximately 65-minute online post-treatment visit after completing the 14-day treatment, which will include audio and videorecorded clinical interview and questionnaires. - Attend an approximately 55-minute online follow-up visit 30 days after completing the treatment, which will include audio and videorecorded clinical interview and questionnaires.

$100

No
 

Valerie Swisher
Valerie Swisher - at vss5199@psu.edu or 909-815-4117
Division of Graduate Studies (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
STUDY00029933
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Be fluent in English
Be at least 18 years old
Have access to a smartphone
Experiences OCD Symptoms

Exclusion Criteria:
Not fluent in English
Do not experience OCD symptoms
Do not own a smart phone
Under age 18
Mental & Behavioral Health
I'm interested
Share via email

BCC025: A Beat Childhood Cancer Research Consortium Phase II Trial of Transplant-Free Chemo-immunotherapy Consolidation Regimen with Naxitamab for High-Risk Neuroblastoma

This protocol is testing a transplant-free consolidation approach for high-risk neuroblastoma by replacing autologous stem cell transplant with naxitamab-based chemoimmunotherapy, followed by standard anti-GD2 immunotherapy and 2 years of DFMO maintenance, with long-term follow-up for efficacy and toxicity outcomes.

Participants will receive treatment in three phases, after completing induction therapy: 1. Consolidation Phase (about 6 cycles) o Patients receive: - Naxitamab, an antibody that helps the immune system find and attack neuroblastoma cells - Chemotherapy drugs (irinotecan and temozolomide) - GM-CSF, a medicine that boosts immune cell activity - Radiation therapy 2. Immunotherapy Phase (6 cycles) o Most cycles include: - Dinutuximab (another anti-neuroblastoma antibody) - GM-CSF - Isotretinoin (a vitamin A–related medication that helps prevent neuroblastoma cells from growing) o The final cycle uses isotretinoin alone. 3. Maintenance Phase o Patients take DFMO every day for 2 years to help reduce the chance that the cancer comes back. o For patients whose tumors have certain ALK gene changes, an additional targeted medication (an ALK inhibitor) may be added.

Yes
 

Lisa McGregor
Jennifer Irving - at pshpedoncintake@pennstatehealth.psu.edu or 717-531-4781
Pediatrics: Hematology/Oncology (HERSHEY)
 

All
All
This study is NOT accepting healthy volunteers
NCT07932808
STUDY00030393
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
21 years old or younger when diagnosed with high-risk neuroblastoma
Older than 1 year of age when entering the study
Confirmed diagnosis of high-risk neuroblastoma
Children whose cancer was not high-risk at first but later became high risk may also qualify
Have completed 5 to 7 cycles of chemotherapy and had surgery to remove as much tumor as possible

Exclusion Criteria:
Age less than 1 year
The child's cancer got worse during the later part of their initial treatment (after the fourth cycle of chemotherapy)
The child needed extra treatment beyond the standard 5 to 7 cycles of chemotherapy to get the cancer under control
The child is currently taking an experimental (investigational) drug
The child is currently receiving other cancer treatments outside of the study
Cancer
Approved drug(s)
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

The Effects of Music on Pain

The purpose of this research study is to explore how pain changes when listening to different music. Participants will be exposed to different songs, and they will receive several painful but tolerable heat stimulations on their arm. They will then be asked to rate how painful they found each stimulus. Before and after the task, they will respond to additional surveys.

The study includes one in-person visit. Participants will be exposed to different songs, they will receive several painful but tolerable heat stimulations on their forearms and will be asked to rate how painful they found them. They will then be asked a few questions about the songs.

Up to $40

Yes
 

Elizabeth Losin
Amber Floyd - at losin.lab@psu.edu
Biobehavioral Health (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00029653
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Adults aged 18-55 years old
Fluent English speaker
Living in the United States
Normal hearing or corrective normal hearing
Available to participate in-person

Exclusion Criteria:
History of pain disorders
History of neurological or systemic disorder which can cause cognitive impairment
Current presence of pain
Severe cardiovascular disease
Scar tissue on both forearms
Mental & Behavioral Health, Pain Management
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

Collaborative Research: Brain-AI Alignment in Generative and Exploratory Design Through Neuroimaging

This study looks at how people come up with and improve ideas for everyday design problems, and how their thinking compares with the way artificial intelligence (AI) computer programs represent the same ideas. At Penn State, adult volunteers (age 18 or older) will lie in a magnetic resonance imaging (MRI) scanner for about 1 hour while they think of ideas for design problems and describe them out loud. The scanner measures brain activity (functional MRI, or fMRI), and spoken answers are audio recorded. The visit takes about 1.5 hours at Penn State's Social, Life, and Engineering Sciences Imaging Center on the University Park campus. Participants are paid $20 per hour.

One in-person visit of about 1.5 hours at Penn State's Social, Life, and Engineering Sciences Imaging Center (SLEIC). Participants answer brief background questions, then lie in an MRI scanner for about 1 hour while they think of ideas for everyday design problems and describe them out loud. Spoken answers are audio recorded.

Approximately $30 ($20/hour)

Yes
 

Roger Beaty
Roger Beaty - at rub736@psu.edu or 814-863-8524
Psychology (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00029721
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Adults age 18 years or older
Able to provide informed consent
Fluent or proficient in English
Able to complete computer-based design tasks
Meets MRI safety requirements (checked by a brief screening before the visit)

Exclusion Criteria:
Under 18 years old
Unable or unwilling to provide informed consent
MRI contraindications (e.g., pacemaker, metal implants or fragments)
Neurological condition or head injury that may affect participation
Pregnant at the time of MRI scanning
Education, Neurology, Mental & Behavioral Health
Survey(s)
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,